Abstracts
2 3 Gesellschaft für empirische Beratung mbH, D-79211 Denzlingen, Germany OBJECTIVES: In the present study, physicians' beliefs about patients' preferences regarding the treatment of MM were explored in a direct assessment and a Discrete Choice Experiment (DCE) and were compared to the previously explored patients' preferences. METHODS: In a preceding DCE with MM-patients, relevant attributes of an ideal MM-treatment were collected by reviewing the literature and by conducting a qualitative study with four focus groups. The attributes were analyzed in a subsequent quantitative study using both a direct measurement (16 items on a 5-point Likert-scale) and a DCE (8 pairs with 8 characteristics). In the present study, 243 physicians answered (76% male, 62% haematology specialists, 70% with 10 MM-patients in the last 12 months) the identical questionnaire. RESULTS: Physicians rated physical quality of life (specifi ed as "reduced mobility or good mobility"), rare side effects and effectiveness aspects (duration of effect, maximal prolonged life expectancy and effectiveness) as most important attributes from the patients' perspective. While the direct assessment gathers a range of important aspects, weighing particular relevant treatment attributes in a DCE is important. Physicians ranked prolonged life expectancy as most relative important and signifi cantly more important than all other treatment attributes. Further treatment options were second most important and signifi cant compared to breaks in therapy and physical quality of life, whereas the patients ordered these two top priorities reversely. CONCLUSIONS: Over a broad range of treatment attributes the physicians' perceptions of preferences were very close to those of MM patients. However in the DCE, after weighing the attributes patients assigned a higher relative importance to further treatment options and "Not always think of the disease", but less to prolonged life expectancy and self-application.
PCN79 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF NON-HODGKIN LYMPHOMA IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE
Balderas-Peña LMA 1 , Contreras-Hernandez I 2 , Mould-Quevedo J 3 , Garduño-Espinosa J 2 , Morgan-Villela G 4 1 Social Security Mexican Institute, pecialties' Hospital. Western National Medical Center, Guadalajara, Mexico, 2 Social Security Mexican Institute, Mexico City, Mexico, 3 Pfi zer Mexico, Mexico City, Mexico, 4 Social Security Mexican Institute, Guadalajara, Mexico OBJECTIVES: The aim of this study was to describe health related quality of life in different stages of non-hodgkin lymphoma in patients attended in a tertiary referral center at the Social Security Mexican Institute. METHODS: Were included outpatients with non-hodgkin lymphoma, attended in a tertiary referral center since July to August 2008, with the following inclusion criteria: older than 16 years, non-hodgkin lymphoma histological diagnosis, were included through informed consent; were excluded patients with second malignant neoplasm or incomplete information. To calculate health related quality of life EORTC QLQ-C30 score validated Spanish version to México was used; were evaluated global health status, functional scales (physical, role, emotional, cognitive, social) and symptom scales (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, fi nancial diffi culties) in scale since 0 to 100 (0 death, 100 perfect health). Were calculated means and range for EORTC QLQ-C30 score items; statistical differences were calculated through ANOVA test, p value 0.05 was considered signifi cant. RESULTS:
We studied 14 non-hodgkin lymphoma patients, mean age group was 60 12.3 years old, 57% were women, 78% were married, and 23% had an educational level of incomplete elementary school. The stating of this group was distributed as follow: I-7%, II-14%, III-7% and NC (non classifi ed)-72% (without complete histopathology report at interview moment). Health related quality of life mean for all items was: I:88.2, II:87.6, III:48.11, according clinical stage in NC group was 75.1; p 0.23. The assumptions associated with a decreased health related quality of life associated with disease progression were emotional function (I-83, II-63, III-66; p 0.05), cognitive function (I-10, II-83, III-50, IV-56; p 0.06). CONCLUSIONS: We observed a decreased health related quality of life associated with a late clinical stage in emotional and cognitive function.
PCN80 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF BREAST CANCER IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE
Balderas-Peña LMA 1 , Contreras-Hernandez I 2 , Mould-Quevedo J 3 , Sat-Muñoz D 4 , Garduño-Espinosa J 2 , Morgan-Villela G 4 1 Social Security Mexican Institute, pecialties' Hospital. Western National Medical Center, Guadalajara, Mexico, 2 Social Security Mexican Institute, Mexico City, Mexico, 3 Pfi zer Mexico, Mexico City, Mexico, 4 Social Security Mexican Institute, Guadalajara, Mexico OBJECTIVES: The aim of this study was to describe health related quality of life in different stages of breast cancer in patients attended in a tertiary referral center at the Social Security Mexican Institute. METHODS: Were included outpatients with breast cancer, attended in a tertiary referral center since July to August 2008, with the following inclusion criteria: older than 16 years, breast cancer histological diagnosis, accepted were included through informed consent, were excluded patients with second malignant neoplasm or incomplete information. To calculate health related quality of life EORTC QLQ-C30 score validated Spanish version to México was used; were evaluated global health status, functional scales (physical, role, emotional, cognitive, social) and symptom scales (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, fi nancial diffi culties) in scale since 0 to 100 (0 death, 100 perfect health). Were calculated means and range for EORTC QLQ-C30 score items; statistical differences were calculated through ANOVA test, p value 0.05 was considered signifi cant. RESULTS: We studied 148 breast cancer patients, mean age 51.68 10.32 years old, 69% were married, and 20% had an educational level of preparatory school. The stating of this group was distributed according clinical stage as follow: I-6%, II-23%, III-16%, IV-7% without stage at interview moment (NC) 47% (fi rst visit for diagnosis). Health related quality of life mean for all items was: I:85.7 7, II:75.36 15, III:74.47 17 and IV:61.05 22, NC:76 18 (p 0.07). The assumptions associated with a decreased health related quality of life in relation to late clinical stage were physical function (I-88, II-79, III-75, IV-56; p 0.003), role function (I-90, II-80, III-71, IV-43; p 0.001), weakness (I-83, II-66, III-62, IV-44; p 0.004) and pain (I-85, II-70, III-65, IV-50; p 0.05). CONCLUSIONS: We observed decreased health related quality of life in late clinical stage. An important factor with impact in quality life could be adverse events related with adjuvant treatments.
PCN81 HEALTH RELATED QUALITY OF LIFE IN THE DIFFERENT STAGES OF COLORECTAL CANCER IN PATIENTS ATTENDED IN THE SOCIAL SECURITY MEXICAN INSTITUTE
Contreras-Hernandez I 1 , Balderas-Peña LMA 2 , Mould-Quevedo J 3 , Garduño-Espinosa J 1 , Morgan-Villela G 4 1 Social Security Mexican Institute, Mexico City, Mexico, 2 Social Security Mexican Institute, pecialties' Hospital. Western National Medical Center, Guadalajara, Mexico, 3 Pfi zer Mexico, Mexico City, Mexico, 4 Social Security Mexican Institute, Guadalajara, Mexico OBJECTIVES: The aim of this study was to describe health related quality of life in different stages of colorectal cancer in patients attended in a tertiary referral center at the Social Security Mexican Institute. METHODS: Were included outpatients with colorectal cancer, attended in a tertiary referral center since July to August 2008, with the following inclusion criteria: older than 16 years, colorectal cancer histological diagnosis, accepted were included through informed consent; were excluded patients with second malignant neoplasm or incomplete information. To calculate health related quality of life EORTC QLQ-C30 score validated Spanish version to México was used; were evaluated global health status, functional scales (physical, role, emotional, cognitive, social) and symptom scales (fatigue, nausea and vomiting, pain, dyspnea, insomnia, appetite loss, constipation, diarrhea, fi nancial diffi culties) in scale since 0 to 100 (0 death, 100 perfect health). Were calculated means and range for EORTC QLQ-C30 score items; statistical differences were calculated through ANOVA test, p value 0.05 was considered signifi cant. RESULTS: We studied 31 colorectal cancer patients, mean age patients was 55 11.5 years old, 54% were women, 71% were married, and 38% had secondary school. The stating of this group was distributed as follow: II-4 (13%), III-2 (6%) IV-7 (23%) and NC (non-classifi ed)-18 (58%) (without complete histopathology report). Health related quality of life mean according stage for all items was: II:57 22, III:86 12 and IV:66 14 NC 76 19 (p 0.17) The assumptions associated with a decreased health related quality of life associated with disease progression were pain (II-20, III-75, IV-52;p 0.02) and fi nancial problems (II-25, III-100, IV-76;p 0.09. CONCLUSIONS: We observed a decreased health related quality of life associated with late clinical stage by pain and fi nancial problems.
